...
首页> 外文期刊>Drug Metabolism and Disposition: The Biological Fate of Chemicals >Suppression of xenobiotic-metabolizing enzyme expression in rats by acriflavine, a protein kinase C inhibitor. Effects on epoxide hydrolase, glutathione S-transferases, and cytochromes p450.
【24h】

Suppression of xenobiotic-metabolizing enzyme expression in rats by acriflavine, a protein kinase C inhibitor. Effects on epoxide hydrolase, glutathione S-transferases, and cytochromes p450.

机译:通过蛋白激酶C抑制剂acriflavine抑制大鼠异种代谢酶的表达。对环氧水解酶,谷胱甘肽S-转移酶和细胞色素p450的影响。

获取原文
获取原文并翻译 | 示例

摘要

The effects of acriflavine (ACF), a protein kinase C inhibitor, on the expression of hepatic microsomal epoxide hydrolase (mEH), glutathione S-transferases (GSTs), and cytochrome P450 (P450) were assessed in rat hepatic tissue. Northern blot analysis revealed that treatment of rats with thiazole, allyl disulfide (ADS), oltipraz, or clotrimazole at a single dose of 100 mg/kg resulted in 7-18-fold increases in mEH mRNA levels at 24 hr, whereas concomitant ACF treatment (20 mg/kg, im) caused 50-95% inhibition of the chemical-induced increases in hepatic mEH mRNA levels. rGSTA2, rGSTA3, and rGSTM1 mRNA levels were also significantly suppressed at 24 hr in response to a single dose of ACF (20 mg/kg, im). Animals treated with both ACF and ADS showed complete blockage of mEH and GST gene expression as early as 12 hr after treatment. ADS-inducible increases in mEH and rGSTA2 mRNA levels were suppressed at 24 hr after treatment with ACF, in a dose-related manner, with 50% inhibitory dose (ID50) values of 2.0-2.3 mg/kg, whereas glyceraldehyde-3-phosphate dehydrogenase mRNA levels were not altered. Immunoblot analysis revealed that ACF (15 mg/kg/day, im, for 3 days) inhibited induction of mEH or rGSTA2 protein by ADS (100 mg/kg/day, po, for 3 days). The levels of hepatic P450 2B1/2, P450 2C11, and P450 3A1/2 were decreased in rats treated with ACF (15 mg/kg/day, im, for 3 days), whereas P450 1A2 and P450 2E1 expression was not affected. Treatment of rats with ACF in combination with gadolinium chloride, which inhibits mEH and GST expression through calcium channel blocking, shifted the dose-inhibitory response curves for ACF to the left, with 7-15-fold decreases in the ID50 values, indicating that the active site for ACF for suppression of mEH and GST mRNA levels differs from that for gadolinium chloride. Proflavine and safranine O, which are structurally related to ACF, also caused suppression of ADS-induced increases in mRNA levels, in a dose-dependent manner, with ID50 values of 4-9 mg/kg. These results demonstrate that ACF and its related compounds effectively suppress the expression of a battery of hepatic xenobiotic-metabolizing enzymes, including mEH, GSTs, and certain P450 forms.
机译:评估了大鼠肝脏组织中蛋白激酶C抑制剂a啶黄(ACF)对肝微粒体环氧化物水解酶(mEH),谷胱甘肽S-转移酶(GSTs)和细胞色素P450(P450)表达的影响。 Northern印迹分析显示,单剂量100 mg / kg的噻唑,二硫化烯丙酯(ADS),oltipraz或克霉唑处理的大鼠在24小时时会导致mEH mRNA水平增加7-18倍,而同时进行ACF处理(20 mg / kg,im)对化学诱导的肝mEH mRNA水平升高的抑制作用为50-95%。 rGSTA2,rGSTA3和rGSTM1 mRNA水平在24小时对单剂量ACF(20 mg / kg,im)的反应也被显着抑制。用ACF和ADS进行处理的动物最早在处理后12小时就显示出mEH和GST基因表达的完全阻断。在ACF治疗后24小时,ADS诱导的mEH和rGSTA2 mRNA水平的升高以剂量相关的方式被抑制,其50%抑制剂量(ID50)值为2.0-2.3 mg / kg,而甘油醛3-磷酸脱氢酶mRNA水平未改变。免疫印迹分析显示,ACF(15 mg / kg /天,即时,持续3天)抑制ADS诱导mEH或rGSTA2蛋白(100 mg / kg /天,口服,持续3天)。在用ACF(15 mg / kg / day,im,3天)处理的大鼠中,肝P450 2B1 / 2,P450 2C11和P450 3A1 / 2的水平降低,而P450 1A2和P450 2E1的表达不受影响。用ACF联合氯化combination对大鼠的治疗通过氯化钙通道阻滞抑制mEH和GST表达,将ACF的剂量抑制反应曲线向左移动,ID50值降低7-15倍,表明抑制mEH和GST mRNA水平的ACF活性位点与氯化g的活性位点不同。结构上与ACF有关的黄酮和红花O也以剂量依赖性方式抑制ADS诱导的mRNA水平增加,ID50值为4-9 mg / kg。这些结果表明,ACF及其相关化合物可有效抑制一系列肝异源代谢酶(包括mEH,GST和某些P450形式)的表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号